Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1948 1
1971 1
2003 1
2007 1
2008 2
2009 2
2010 4
2011 4
2012 1
2013 4
2014 3
2015 5
2016 5
2017 5
2018 5
2019 4
2020 11
2021 11
2022 6
2023 6
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

71 results

Results by year

Filters applied: . Clear all
Page 1
ASCL1 promotes Scrt2 expression in the neural tube.
Goes CP, Botezelli VS, De La Cruz SM, Cruz MC, Azambuja AP, Simoes-Costa M, Yan CYI. Goes CP, et al. Among authors: azambuja ap. Front Cell Dev Biol. 2024 Apr 5;12:1324584. doi: 10.3389/fcell.2024.1324584. eCollection 2024. Front Cell Dev Biol. 2024. PMID: 38655067 Free PMC article.
RESILIENT Part 2: A Randomized, Open-Label Phase III Study of Liposomal Irinotecan Versus Topotecan in Adults With Relapsed Small Cell Lung Cancer.
Spigel DR, Dowlati A, Chen Y, Navarro A, Yang JC, Stojanovic G, Jove M, Rich P, Andric ZG, Wu YL, Rudin CM, Chen H, Zhang L, Yeung S, Benzaghou F, Paz-Ares L, Bunn PA; RESILIENT Trial Investigators. Spigel DR, et al. J Clin Oncol. 2024 Apr 22:JCO2302110. doi: 10.1200/JCO.23.02110. Online ahead of print. J Clin Oncol. 2024. PMID: 38648575
Case report: CD8 positive T-cell Prolymphocytic Leukemia presenting complex karyotype with a rare chromosomal abnormality der(2)t(1;2)(q21;q37) and additional signals of the genes MYC, IGH, and TP53.
Jamur VR, Lisboa MO, Azambuja AP, Brofman PRS. Jamur VR, et al. Among authors: azambuja ap. Hematol Transfus Cell Ther. 2023 Aug 29:S2531-1379(23)00164-5. doi: 10.1016/j.htct.2023.07.009. Online ahead of print. Hematol Transfus Cell Ther. 2023. PMID: 37704564 Free article. No abstract available.
Cabozantinib plus Nivolumab and Ipilimumab in Renal-Cell Carcinoma.
Choueiri TK, Powles T, Albiges L, Burotto M, Szczylik C, Zurawski B, Yanez Ruiz E, Maruzzo M, Suarez Zaizar A, Fein LE, Schutz FA, Heng DYC, Wang F, Mataveli F, Chang YL, van Kooten Losio M, Suarez C, Motzer RJ; COSMIC-313 Investigators. Choueiri TK, et al. N Engl J Med. 2023 May 11;388(19):1767-1778. doi: 10.1056/NEJMoa2212851. N Engl J Med. 2023. PMID: 37163623 Free PMC article. Clinical Trial.
Multicentric standardization of minimal/measurable residual disease in B-cell precursor acute lymphoblastic leukaemia using next-generation flow cytometry in a low/middle-level income country.
Ikoma-Colturato MRV, Bertolucci CM, Conti-Spilari JE, Oliveira E, Simioni AJ, Figueredo-Pontes LL, Furtado FM, Alegretti AP, Azambuja AP, Gevert F, Gomes BE, Avelar DMV, Soares ACCV, Ramos PM, Santos B, Cortez ML, Beltrame MP, Bacal NS, Wagner A, Lucena-Silva N, Sandes AF, Cunha F, Oliveira GHM, Costa ES, Yamamoto M. Ikoma-Colturato MRV, et al. Among authors: azambuja ap. Br J Haematol. 2023 Feb;200(3):381-384. doi: 10.1111/bjh.18499. Epub 2022 Oct 12. Br J Haematol. 2023. PMID: 36222259 Free PMC article. No abstract available.
Evaluation of lymphocyte count, T-cell subsets and neutrophil-to-lymphocyte ratio as early predictors for severity and outcome of COVID-19 disease-a report from a highly complex hospital in Brazil.
Oliveira DC, Spiri BS, Schluga YC, Justus JLP, Lopes Neto FDN, Azambuja AP. Oliveira DC, et al. Among authors: azambuja ap. Hematol Transfus Cell Ther. 2023 Jul-Sep;45(3):330-337. doi: 10.1016/j.htct.2022.05.007. Epub 2022 Jun 29. Hematol Transfus Cell Ther. 2023. PMID: 35782909 Free PMC article.
Safety and long-term improvement of mesenchymal stromal cell infusion in critically COVID-19 patients: a randomized clinical trial.
Rebelatto CLK, Senegaglia AC, Franck CL, Daga DR, Shigunov P, Stimamiglio MA, Marsaro DB, Schaidt B, Micosky A, de Azambuja AP, Leitão CA, Petterle RR, Jamur VR, Vaz IM, Mallmann AP, Carraro Junior H, Ditzel E, Brofman PRS, Correa A. Rebelatto CLK, et al. Among authors: de azambuja ap. Stem Cell Res Ther. 2022 Mar 21;13(1):122. doi: 10.1186/s13287-022-02796-1. Stem Cell Res Ther. 2022. PMID: 35313959 Free PMC article. Clinical Trial.
71 results